Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Gastroenterology. 2010 Mar 6;138(7):2321–2331.e2. doi: 10.1053/j.gastro.2010.02.058

Figure 1.

Figure 1

Description of the HALT-C Trial cohort. Amongst the 744 patients without baseline varices, 441 continued to have no detectable varices during follow-up while 157 developed new gastroesophageal varices. Amongst the 272 patients with baseline gastroesophageal varices, 136 patients had stable or improved varices while 74 subjects had worsening varices.